Innate Pharma to Spotlight Oncology Pipeline at H.C. Wainwright Investor ConferenceTip Ranks·10 hours agoIPHA+1.89%
Innate Pharma prices private placement of new shares at EUR 1.7 eachPUBT·Aug 19 at 08:03 PMIPHA+1.89%
Bpifrance Participations, Innate Pharma board director, purchases EUR 3 million of Innate Pharma sharesPUBT·Aug 14 at 04:33 PMIPHA+1.89%
IPH: Three late-stage oncology assets drive value, with major partnerships and pivotal data due in H2 2026Quartr·Aug 14 at 02:45 PMIPHA+1.89%AZN-0.06%
IPH: €30 million share offering priced, extending cash runway and funding clinical pipelineQuartr·Aug 14 at 12:05 PMIPHA+1.89%
Innate Pharma Announces Conference Call and Webcast | IPHA Stock NewsStockTitan·Aug 14 at 01:30 AMIPHA+1.89%
BTIG Research Issues Positive Forecast for Innate Pharma (NASDAQ:IPHA) Stock PriceMarket Beat·Aug 12 at 12:06 PMIPHA+1.89%
Innate Pharma S.A. Sponsored ADR (NASDAQ:IPHA) Given Average Rating of "Moderate Buy" by AnalystsMarket Beat·Aug 11 at 12:14 PMIPHA+1.89%
